Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2018 (2018), Article ID 5635010, 19 pages
https://doi.org/10.1155/2018/5635010
Review Article

Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering

Dry Powder Inhaler Lab, Respiratory Formulations, Cipla R&D, LBS Marg Road, Vikhroli (West), Mumbai, Maharashtra 400079, India

Correspondence should be addressed to Piyush Mehta; moc.liamg@350uyip

Received 28 August 2017; Accepted 6 December 2017; Published 14 January 2018

Academic Editor: Philippe Maincent

Copyright © 2018 Piyush Mehta. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. S. Razavi Rohani, K. Abnous, and M. Tafaghodi, “Preparation and characterization of spray-dried powders intended for pulmonary delivery of Insulin with regard to the selection of excipients,” International Journal of Pharmaceutics, vol. 465, no. 1-2, pp. 464–478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Mehta, “Dry powder inhalers: a focus on advancements in novel drug delivery systems,” Journal of Drug Delivery, vol. 2016, pp. 1–17, 2016. View at Publisher · View at Google Scholar
  3. P. Muralidharan, D. Hayes, and H. M. Mansour, “Dry powder inhalers in COPD, lung inflammation and pulmonary infections,” Expert Opinion on Drug Delivery, vol. 12, no. 6, pp. 947–962, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. H. W. Frijlink and A. H. De Boer, “Dry powder inhalers for pulmonary drug delivery,” Expert Opinion on Drug Delivery, vol. 1, no. 1, pp. 67–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Hamishehkar, Y. Rahimpour, and Y. Javadzadeh, “The role of carrier in dry powder inhaler,” in Recent Advances in Novel Drug, A. Sezer, Ed., pp. 39–66, Croatia, InTech, 2012. View at Google Scholar
  6. T. Peng, S. Lin, B. Niu et al., “Influence of physical properties of carrier on the performance of dry powder inhalers,” Acta Pharmaceutica Sinica B (APSB), vol. 6, no. 4, pp. 308–318, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Grasmeijer, A. J. Lexmond, M. Van Den Noort et al., “New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalation,” PLoS ONE, vol. 9, no. 1, Article ID e87825, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Kaialy and A. Nokhodchi, “Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: effect of saturation degree,” International Journal of Pharmaceutics, vol. 437, no. 1-2, pp. 57–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Young, R. Price, S. Edge, J. Kaerger, and M. Tobyn, “Carriers for DPIs: formulation and regulatory challenges,” Pharmaceutical Technology Europe PTE, vol. 18, 2006. View at Google Scholar
  10. A. Nokhodchi and H. Larhrib, “Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles,” Therapeutic Delivery, vol. 4, no. 8, pp. 879–882, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. H. L. Chow, H. H. Y. Tong, P. Chattopadhyay, and B. Y. Shekunov, “Particle engineering for pulmonary drug delivery,” Pharmaceutical Research, vol. 24, no. 3, pp. 411–437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Buttini, P. Colombo, A. Rossi, F. Sonvico, and G. Colombo, “Particles and powders: tools of innovation for non-invasive drug administration,” Journal of Controlled Release, vol. 161, no. 2, pp. 693–702, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Gradon and T. R. Sosnowski, “Formation of particles for dry powder inhalers,” Advanced Powder Technology, vol. 25, no. 1, pp. 43–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Thieme, S. Agarwal, J. H. Wendorff, and A. Greiner, “Electrospinning and cutting of ultrafine bioerodible poly(lactide-co-ethylene oxide) tri- and multiblock copolymer fibers for inhalation applications,” Polymers for Advanced Technologies, vol. 22, no. 9, pp. 1335–1344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Shoyele and S. Cawthorne, “Particle engineering techniques for inhaled biopharmaceuticals,” Advanced Drug Delivery Reviews, vol. 58, no. 9-10, pp. 1009–1029, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Patil-Gadhe and V. Pokharkar, “Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach,” Pulmonary Pharmacology and Therapeutics, vol. 27, no. 2, pp. 197–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Fox and P. McSweeney, Dairy Chemistry and Biochemistry, Springer, Berlin, Germany, 1998.
  18. R. Jawad, G. Martin, and P. Royall, “Chemical and compositional characterization of lactose as a carrier in dry powder inhalers,” in Pulmonary drug delivery: advances, A. Nokhodchi and G. Martin, Eds., pp. 143–169, Wiley, NY, USA, 2015. View at Google Scholar
  19. W. Kaialy and A. Nokhodchi, “Particle engineering for improved pulmonary drug delivery through dry powder inhalers'', in Pulmonary drug delivery: advances and,” in Pulmonary drug delivery: advances and challenges, A. Nokhodchi and G. Martin, Eds., pp. 171–197, Wiley, New York, NY, USA, 2015. View at Google Scholar
  20. W. Kaialy, H. Larhrib, M. Ticehurst, and A. Nokhodchi, “Influence of batch cooling crystallization on mannitol physical properties and drug dispersion from dry powder inhalers,” Crystal Growth and Design, vol. 12, no. 6, pp. 3006–3017, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. A. Lonare and S. R. Patel, “Antisolvent crystallization of poorly water soluble drugs,” International Journal of Chemical Engineering and Applications, pp. 337–341, 2013. View at Publisher · View at Google Scholar
  22. S. Y. Wong and R. W. Hartel, “Crystallization in lactose refining-a review,” Journal of Food Science, vol. 79, no. 3, pp. R257–R272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Larhrib, G. P. Martin, D. Prime, and C. Marriott, “Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers,” European Journal of Pharmaceutical Sciences, vol. 19, no. 4, pp. 211–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Kaialy, G. P. Martin, M. D. Ticehurst et al., “Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers,” The AAPS Journal, vol. 13, no. 1, pp. 30–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Kaialy, M. D. Ticehurst, J. Murphy, and A. Nokhodchi, “Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone,” Journal of Pharmaceutical Sciences, vol. 100, no. 7, pp. 2665–2684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Kaialy, G. P. Martin, H. Larhrib, M. D. Ticehurst, E. Kolosionek, and A. Nokhodchi, “The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers,” Colloids and Surfaces B: Biointerfaces, vol. 89, no. 1, pp. 29–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. Crisp, S. E. Dann, and C. G. Blatchford, “Antisolvent crystallization of pharmaceutical excipients from aqueous solutions and the use of preferred orientation in phase identification by powder X-ray diffraction,” European Journal of Pharmaceutical Sciences, vol. 42, no. 5, pp. 568–577, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. L. T. T. Vu, L. Huynh, and J. A. Hourigan, “Effects of solvents on characteristics of crystalline lactose extracted in ternary and quaternary systems,” Advanced Powder Technology, vol. 20, no. 3, pp. 251–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. X. M. Zeng, G. P. Martin, C. Marriott, and J. Pritchard, “Crystallization of lactose from carbopol gels,” Pharmaceutical Research, vol. 17, no. 7, pp. 879–886, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. X. M. Zeng, G. P. Martin, C. Marriott, and J. Pritchard, “The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 51, no. 1, pp. 55–62, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. S. S. Patil, K. R. Mahadik, and A. R. Paradkar, “Liquid crystalline phase as a probe for crystal engineering of lactose: carrier for pulmonary drug delivery,” European Journal of Pharmaceutical Sciences, vol. 68, pp. 43–50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. R. S. Dhumal, S. V. Biradar, A. R. Paradkar, and P. York, “Ultrasound assisted engineering of lactose crystals,” Pharmaceutical Research, vol. 25, no. 12, pp. 2835–2844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S. A. F. S. Muhammad, P. Tang, H.-K. Chan, and F. Dehghani, “The effect of lactose micro-spherical crystals prepared by conditioning with supercritical fluid on salbutamol sulphate inhalation performance,” The Journal of Supercritical Fluids, vol. 71, pp. 92–101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Pilcer and K. Amighi, “Formulation strategy and use of excipients in pulmonary drug delivery,” International Journal of Pharmaceutics, vol. 392, no. 1-2, pp. 1–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi, “Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate,” International Journal of Pharmaceutics, vol. 172, no. 1-2, pp. 179–188, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Bosquillon, P. G. Rouxhet, F. Ahimou et al., “Aerosolization properties, surface composition and physical state of spray-dried protein powders,” Journal of Controlled Release, vol. 99, no. 3, pp. 357–367, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. P. M. Young, P. Kwok, H. Adi, H.-K. Chan, and D. Traini, “Lactose composite carriers for respiratory delivery,” Pharmaceutical Research, vol. 26, no. 4, pp. 802–810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Harjunen, V. Lehto, K. Martimo, E. Suihko, T. Lankinen, and P. Paronen, “Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI,” European Journal of Pharmaceutical Sciences, vol. 16, pp. 313–321, 2002. View at Google Scholar
  39. M. Nikolaou and T. Krasia-Christoforou, “Electrohydrodynamic methods for the development of pulmonary drug delivery systems,” European Journal of Pharmaceutical Sciences, 2017. View at Publisher · View at Google Scholar
  40. S. Patil, A. Mahadik, P. Nalawade, and P. More, “Crystal engineering of lactose using electrospray technology: carrier for pulmonary drug delivery,” Drug Development and Industrial Pharmacy, vol. 43, no. 12, pp. 2085–2091, 2017. View at Publisher · View at Google Scholar
  41. B. M. J. Tan, L. W. Chan, and P. W. S. Heng, “Improving dry powder inhaler performance by surface roughening of lactose carrier particles,” Pharmaceutical Research, vol. 33, no. 8, pp. 1923–1935, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. P. M. Young, D. Cocconi, P. Colombo et al., “Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing",” Journal of Pharmacy and Pharmacology, vol. 54, no. 10, pp. 1339–1344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Patton and R. Platz, “Pulmonary delivery of peptides and proteins for systemic action,” Advanced Drug Delivery Reviews, vol. 8, pp. 179–228, 1992. View at Google Scholar
  44. Y. Rahimpour, M. Kouhsoltani, and H. Hamishehkar, “Alternative carriers in dry powder inhaler formulations,” Drug Discovery Therapy, vol. 19, no. 5, pp. 618–626, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Kaialy, G. P. Martin, M. D. Ticehurst, M. N. Momin, and A. Nokhodchi, “The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient,” International Journal of Pharmaceutics, vol. 392, no. 1-2, pp. 178–188, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Kaialy, M. N. Momin, M. D. Ticehurst, J. Murphy, and A. Nokhodchi, “Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler,” Colloids and Surfaces B: Biointerfaces, vol. 79, no. 2, pp. 345–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Kaialy, A. Alhalaweh, S. P. Velaga, and A. Nokhodchi, “Effect of carrier particle shape on dry powder inhaler performance,” International Journal of Pharmaceutics, vol. 421, no. 1, pp. 12–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Kaialy and A. Nokhodchi, “Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations,” The AAPS Journal, vol. 15, no. 3, pp. 728–743, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Kaialy and A. Nokhodchi, “Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs,” International Journal of Pharmaceutics, vol. 448, no. 1, pp. 58–70, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Kaialy, H. Larhrib, G. P. Martin, and A. Nokhodchi, “The effect of engineered mannitol-lactose mixture on dry powder inhaler performance,” Pharmaceutical Research, vol. 29, no. 8, pp. 2139–2156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. E. M. Littringer, A. Mescher, H. Schroettner, L. Achelis, P. Walzel, and N. A. Urbanetz, “Spray dried mannitol carrier particles with tailored surface properties - The influence of carrier surface roughness and shape,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 82, no. 1, pp. 194–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. P. M. Young, D. Roberts, H. Chiou, W. Rae, H.-K. Chan, and D. Traini, “Composite carriers improve the aerosolisation efficiency of drugs for respiratory delivery,” Journal of Aerosol Science, vol. 39, no. 1, pp. 82–93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. W. Kaialy, T. Hussain, A. Alhalaweh, and A. Nokhodchi, “Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres,” Pharmaceutical Research, vol. 31, no. 1, pp. 60–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Tang, H.-K. Chan, H. Chiou et al., “Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets,” International Journal of Pharmaceutics, vol. 367, no. 1-2, pp. 51–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. W. Kaialy and A. Nokhodchi, “Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler,” Pharmaceutical Research, vol. 30, no. 2, pp. 458–477, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Kaialy and A. Nokhodchi, “Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol,” European Journal of Pharmaceutical Sciences, vol. 68, pp. 56–67, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Kaialy and A. Nokhodchi, “The use of freeze-dried mannitol to enhance the in vitro aerosolization behaviour of budesonide from the Aerolizer®,” Powder Technology, vol. 288, pp. 291–302, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Ohashi, T. Kabasawa, T. Ozeki, and H. Okada, “One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis,” Journal of Controlled Release, vol. 135, no. 1, pp. 19–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Adi, P. M. Young, H.-K. Chan, H. Agus, and D. Traini, “Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease,” European Journal of Pharmaceutical Sciences, vol. 40, no. 3, pp. 239–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Pomázi, F. Buttini, R. Ambrus, P. Colombo, and P. Szabó-Révész, “Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam,” European Polymer Journal, vol. 49, no. 9, pp. 2518–2527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Malamatari, S. Somavarapu, K. Kachrimanis, M. Bloxham, K. M. G. Taylor, and G. Buckton, “Preparation of theophylline inhalable microcomposite particles by wet milling and spray drying: The influence of mannitol as a co-milling agent,” International Journal of Pharmaceutics, vol. 514, no. 1, pp. 200–211, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Rowe, P. Sheskey, and M. Quinn, Handbook of pharmaceutical excipients'', Pharmaceutical Press, UK, 2012.
  63. H. M. Mansour, Z. Xu, and A. J. Hickey, “Dry powder aerosols generated by standardized entrainment tubes from alternative sugar blends: 3. Trehalose dihydrate and D-mannitol carriers,” Journal of Pharmaceutical Sciences, vol. 99, no. 8, pp. 3430–3441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Bosquillon, C. Lombry, V. Préat, and R. Vanbever, “Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance,” Journal of Controlled Release, vol. 70, no. 3, pp. 329–339, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Hickey and H. Mansour, “Formulation challenges of powders for the delivery of small molecular weight molecules as aerosols,” in Modified-release drug, M. Rathbone, J. Hadgraft, M. Roberts, and M. Lane, Eds., pp. 573–602, Informa Healthcare, NY, USA, 2008. View at Google Scholar
  66. X. Li and H. M. Mansour, “Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery,” AAPS PharmSciTech, vol. 12, no. 4, pp. 1420–1430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. R. J. Garmise, H. F. Staats, and A. J. Hickey, “Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination,” AAPS PharmSciTech, vol. 8, no. 4, pp. 2–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. H. M. Mansour and A. J. Hickey, “Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review,” AAPS PharmSciTech, vol. 8, no. 4, pp. 140–155, 2007. View at Publisher · View at Google Scholar
  69. L. M. Crowe, D. S. Reid, and J. H. Crowe, “Is trehalose special for preserving dry biomaterials?” Biophysical Journal, vol. 71, no. 4, pp. 2087–2093, 1996. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Sou, D. A. V. Morton, M. Williamson, E. N. Meeusen, L. M. Kaminskas, and M. P. McIntosh, “Spray-dried influenza antigen with trehalose and leucine produces an aerosolizable powder vaccine formulation that induces strong systemic and mucosal immunity after pulmonary administration,” Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 28, no. 5, pp. 361–371, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. O. N. Ógáin, J. Li, L. Tajber, O. I. Corrigan, and A. M. Healy, “Particle engineering of materials for oral inhalation by dry powder inhalers. I - Particles of sugar excipients (trehalose and raffinose) for protein delivery,” International Journal of Pharmaceutics, vol. 405, no. 1-2, pp. 23–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Sou, L. M. Kaminskas, T.-H. Nguyen, R. Carlberg, M. P. McIntosh, and D. A. V. Morton, “The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 83, no. 2, pp. 234–243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Cline and R. Dalby, “Predicting the quality of powders for inhalation from surface energy and area,” Pharmaceutical Research, vol. 19, no. 9, pp. 1274–1277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. K. Endo, S. Amikawa, A. Matsumoto, N. Sahashi, and S. Onoue, “Erythritol-based dry powder of glucagon for pulmonary administration,” International Journal of Pharmaceutics, vol. 290, no. 1-2, pp. 63–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. D. Traini, P. M. Young, M. Jones, S. Edge, and R. Price, “Comparative study of erythritol and lactose monohydrate as carriers for inhalation: Atomic force microscopy and in vitro correlation,” European Journal of Pharmaceutical Sciences, vol. 27, no. 2-3, pp. 243–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. S. K. Tee, C. Marriott, X. M. Zeng, and G. P. Martin, “The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate,” International Journal of Pharmaceutics, vol. 208, no. 1-2, pp. 111–123, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. P. Sheth and P. Myrdal, “Excipients utilized for modifying pulmonary drug release,” in Controlled pulmonary drug delivery, H. Smyth and A. Hickey, Eds., pp. 237–263, Springer, NY, USA, 2011. View at Google Scholar
  78. N. Wauthoz and K. Amighi, “Formulation strategies for pulmonary delivery of poorly soluble drugs,” in Pulmonary drug delivery: advances and challenges, A. Nokhodchi and G. Martin, Eds., pp. 89–121, Wiley, NY, USA, 2015. View at Google Scholar
  79. N. Poursina, A. Vatanara, M. R. Rouini, K. Gilani, and A. R. Najafabadi, “The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process,” Acta Pharmaceutica, vol. 66, no. 2, pp. 207–218, 2016. View at Publisher · View at Google Scholar · View at Scopus
  80. M. I. Amaro, L. Tajber, O. I. Corrigan, and A. M. Healy, “Co-Spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose,” Pharmaceutical Research, vol. 32, no. 1, pp. 180–195, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Kadota, A. Senda, T. Ito, and Y. Tozuka, “Feasibility of highly branched cyclic dextrin as an excipient matrix in dry powder inhalers,” European Journal of Pharmaceutical Sciences, vol. 79, pp. 79–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. Q. T. Zhou and D. A. V. Morton, “Drug-lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces,” Advanced Drug Delivery Reviews, vol. 64, no. 3, pp. 275–284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. E. Z. Dahmash and A. R. Mohammed, “Functionalised particles using dry powder coating in pharmaceutical drug delivery: promises and challenges,” Expert Opinion on Drug Delivery, vol. 12, no. 12, pp. 1867–1879, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Tay, S. Das, and P. Stewart, “Magnesium stearate increases salbutamol sulphate dispersion: what is the mechanism?” International Journal of Pharmaceutics, vol. 383, no. 1-2, pp. 62–69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. B. Tan, C. Liew, L. Chan, and P. Heng, “Particle surface roughness-its characterization and impact on dry powder inhaler performance,” in iPulmonary drug delivery: advances, A. Nokhodchi and G. Martin, Eds., pp. 199–222, Wiley, NY, USA, 2015. View at Google Scholar
  86. A. Minne, H. Boireau, M. J. Horta, and R. Vanbever, “Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 70, no. 3, pp. 839–844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. L. Chen, T. Okuda, X.-Y. Lu, and H.-K. Chan, “Amorphous powders for inhalation drug delivery,” Advanced Drug Delivery Reviews, vol. 100, pp. 102–115, 2016. View at Publisher · View at Google Scholar · View at Scopus
  88. F. Dimer, C. de Souza Carvalho-Wodarz, J. Haupenthal, R. Hartmann, and C.-M. Lehr, “Inhalable clarithromycin microparticles for treatment of respiratory infections,” Pharmaceutical Research, vol. 32, no. 12, pp. 3850–3861, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Shott, D. Morton, and R. Davies, A method for preparing a dry powder formulation suitable for inhalation'', Vectura Limited, 2012.
  90. M. Gera, V. Saharan, M. Kataria, and V. Kukkar, “Mechanical methods for dry particle coating processes and their applications in drug delivery and development'',” Recent Patents on Drug Delivery Formulation, vol. 4, no. particle, pp. 58–81, 2010. View at Publisher · View at Google Scholar
  91. X.-B. Yang, X.-B. Wang, W.-S. Pan et al., “Optimization and characterization of dry powder of fanhuncaoin for inhalation based on selection of excipients,” Chemical & Pharmaceutical Bulletin, vol. 59, no. 8, pp. 929–937, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. M. D. A. Muhsin, G. George, K. Beagley, V. Ferro, H. Wang, and N. Islam, “Effects of chemical conjugation of L-Leucine to chitosan on dispersibility and controlled release of drug from a nanoparticulate dry powder inhaler formulation,” Molecular Pharmaceutics, vol. 13, no. 5, pp. 1455–1466, 2016. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Yu, T.-T. Tran, J. Teo, and K. Hadinoto, “Dry powder aerosols of curcumin-chitosan nanoparticle complex prepared by spray freeze drying and their antimicrobial efficacy against common respiratory bacterial pathogens,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 504, pp. 34–42, 2016. View at Publisher · View at Google Scholar · View at Scopus
  94. P. S. Pourshahab, K. Gilani, E. Moazeni, H. Eslahi, M. R. Fazeli, and H. Jamalifar, “Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid,” Journal of Microencapsulation, vol. 28, no. 7, pp. 605–613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. Z. Merchant, K. M. G. Taylor, P. Stapleton et al., “Engineering hydrophobically modified chitosan for enhancing the dispersion of respirable microparticles of levofloxacin,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 88, no. 3, pp. 816–829, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Sou, L. Orlando, M. P. McIntosh, L. M. Kaminskas, and D. A. V. Morton, “Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach,” International Journal of Pharmaceutics, vol. 421, no. 2, pp. 220–229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. H. Faghihi, A. Vatanara, A. R. Najafabadi, V. Ramezani, and K. Gilani, “The use of amino acids to prepare physically and conformationally stable spray-dried IgG with enhanced aerosol performance,” International Journal of Pharmaceutics, vol. 466, no. 1-2, pp. 163–171, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Lechuga-Ballesteros, C. Charan, C. L. M. Stults et al., “Trileucine improves aerosol performance and stability of spray-dried powders for inhalation,” Journal of Pharmaceutical Sciences, vol. 97, no. 1, pp. 287–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. K. Iida, Y. Hayakawa, H. Okamoto, K. Danjo, and H. Luenberger, “Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier,” Chemical & Pharmaceutical Bulletin, vol. 52, no. 4, pp. 444–446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Iida, Y. Hayakawa, H. Okamoto, K. Danjo, and H. Luenberger, “Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate,” Chemical & Pharmaceutical Bulletin, vol. 51, no. 12, pp. 1455–1457, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. K. Iida, H. Todo, H. Okamoto, K. Danjo, and H. Leuenberger, “Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed,” Chemical & Pharmaceutical Bulletin, vol. 53, no. 4, pp. 431–434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. P. Begat, R. Price, H. Harris, D. A. V. Morton, and J. N. Staniforth, “The influence of force control agents on the cohesive-adhesive balance in dry powder inhaler formulations,” KONA Powder and Particle Journal, vol. 23, no. March, pp. 109–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Kumon, Y. Yabe, Y. Kasuya et al., “Applicability of DPI formulations for novel neurokinin receptor antagonist,” International Journal of Pharmaceutics, vol. 356, no. 1-2, pp. 102–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. D. Morton, Q. Zhou, L. Qu, I. Larson, and P. Stewart, “Surface modification of micronized drug powders to improve aerosolization via mechanical dry powder coating,” in Proceedings of the The electronic conference on pharmaceutical sciences, pp. 1–6, 2011.
  105. M. S. Hassan and R. Lau, “Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: Comparison with lactose carrier,” International Journal of Pharmaceutics, vol. 386, no. 1-2, pp. 6–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. R. A. Tuli, T. R. Dargaville, G. A. George, and N. Islam, “Polycaprolactone microspheres as carriers for dry powder inhalers: effect of surface coating on aerosolization of salbutamol sulfate,” Journal of Pharmaceutical Sciences, vol. 101, no. 2, pp. 733–745, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. W. Wong, D. F. Fletcher, D. Traini, H.-K. Chan, and P. M. Young, “The use of computational approaches in inhaler development,” Advanced Drug Delivery Reviews, vol. 64, no. 4, pp. 312–322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. C. A. Ruzycki, E. Javaheri, and W. H. Finlay, “The use of computational fluid dynamics in inhaler design,” Expert Opinion on Drug Delivery, vol. 10, no. 3, pp. 307–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. H. Versteeg and W. Malalasekera, An Introduction to Computational Fluid Dynamics. the finite volume method, Pearson Education Limited, England, UK, 1995.
  110. Z. B. Tong, R. Y. Yang, K. W. Chu, A. B. Yu, S. Adi, and H. K. Chan, “Numerical study of the effects of particle size and polydispersity on the agglomerate dispersion in a cyclonic flow,” Chemical Engineering Journal, vol. 164, no. 2-3, pp. 432–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. Z. B. Tong, S. Adi, R. Y. Yang, H. K. Chan, and A. B. Yu, “Numerical investigation of the de-agglomeration mechanisms of fine powders on mechanical impaction,” Journal of Aerosol Science, vol. 42, no. 11, pp. 811–819, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. Z. B. Tong, B. Zheng, R. Y. Yang, A. B. Yu, and H. K. Chan, “CFD-DEM investigation of the dispersion mechanisms in commercial dry powder inhalers,” Powder Technology, vol. 240, pp. 19–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. T. Suwandecha, W. Wongpoowarak, K. Maliwan, and T. Srichana, “Effect of turbulent kinetic energy on dry powder inhaler performance,” Powder Technology, vol. 267, pp. 381–391, 2014. View at Publisher · View at Google Scholar · View at Scopus